Mucormycosis is a difficult to diagnose rare disease with high morbidity and mortality.
Diagnosis is often delayed, and disease tends to progress rapidly. Urgent surgical and …

The diagnosis and treatment of mucormycosis are challenging. The incidence of the disease
seems to be increasing. Hematological malignancies are the most common underlying …

Mucormycosis is an infection caused by a group of filamentous molds within the order
Mucorales. Infections may result from ingestion of contaminated food, inhalation of spores …

Despite the recent introduction of mold-active agents (posaconazole and isavuconazole), in
addition to amphotericin B products, to our armamentarium against mucormycosis, many …

Mucormycosis is an emerging infectious disease with high rates of associated mortality and
morbidity. Little is known about the characteristics of mucormycosis or …

Mucormycosis are life-threatening fungal infections especially affecting
immunocompromised or diabetic patients. Despite treatment, mortality remains high (from 32 …

Mucormycosis is a deadly opportunistic disease caused by a group of fungus named
mucormycetes. Fungal spores are normally present in the environment and the immune …

Critically ill patients and patients with haematological cancer are HIV-negative populations
at high risk of invasive fungal infections. In intensive-care units, candidaemia and intra …

Invasive fungal infections remain a major cause of morbidity and mortality in
immunocompromised patients, and such infections are a substantial burden to healthcare …

Osteoarticular mycoses are chronic debilitating infections that require extended courses of
antifungal therapy and may warrant expert surgical intervention. As there has been no …